Position in SNDX
as of Jun 30, 2026
· filed Aug 11, 2026
Position Value
$3,674,666
-$95,638 QoQ
Shares Held
168,100
+4.2% QoQ
Ownership
0.188%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#80
of 242 holders
Holding Since
Dec 2020
23 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in SNDX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Swiss National Bank holds $1,788,615,626 across 151 Biotechnology names. SNDX ranks #76 (0.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
717,440 | $356,373,971 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
293,020 | $182,709,690 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
374,080 | $112,609,302 | |
| 4 | RVMD |
Revolution Medicines, Inc.
|
456,331 | $85,461,669 | |
| 5 | RPRX |
Royalty Pharma plc
|
1,159,800 | $65,029,986 | |
| 6 | INSM |
INSMED Inc
|
593,512 | $63,280,249 | |
| 7 | INCY |
Incyte Corp
|
476,874 | $54,058,436 | |
| 8 | MRNA |
Moderna, Inc.
|
679,900 | $47,613,397 |
All Filings in SNDX
Export CSV
23 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $3,674,666 | 168,100 | Shares | Sole | 2026-08-11 | |
| 2026-03-31 | $3,770,304 | 161,400 | Shares | Sole | 2026-05-07 | |
| 2025-12-31 | $3,391,014 | 161,400 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $2,438,522 | 158,500 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $1,538,669 | 164,300 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $1,835,379 | 149,400 | Shares | Sole | 2025-05-12 | |
| 2024-12-31 | $1,975,068 | 149,400 | Shares | Sole | 2025-02-10 | |
| 2024-09-30 | $2,875,950 | 149,400 | Shares | Sole | 2024-11-07 | |
| 2024-06-30 | $3,091,818 | 150,600 | Shares | Sole | 2024-08-08 | |
| 2024-03-31 | $3,584,280 | 150,600 | Shares | Sole | 2024-05-07 | |
| 2023-12-31 | $3,077,264 | 142,400 | Shares | Sole | 2024-02-06 | |
| 2023-09-30 | $1,756,920 | 121,000 | Shares | Sole | 2023-11-08 | |
| 2023-06-30 | $2,496,949 | 119,300 | Shares | Sole | 2023-08-09 | |
| 2023-03-31 | $2,443,584 | 115,700 | Shares | Sole | 2023-05-10 | |
| 2022-12-31 | $3,293,230 | 129,400 | Shares | Sole | 2023-02-08 | |
| 2022-09-30 | $2,722,599 | 113,300 | Shares | Sole | 2022-11-09 | |
| 2022-06-30 | $2,024,048 | 105,200 | Shares | Sole | 2022-08-09 | |
| 2022-03-31 | $1,623,292 | 93,400 | Shares | Sole | 2022-05-09 | |
| 2021-12-31 | $1,867,217 | 85,300 | Shares | Sole | 2022-02-08 | |
| 2021-09-30 | $1,630,083 | 85,300 | Shares | Sole | 2021-11-08 | |
| 2021-06-30 | $1,426,827 | 83,100 | Shares | Sole | 2021-08-06 | |
| 2021-03-31 | $1,656,876 | 74,100 | Shares | Sole | 2021-05-07 | |
| 2020-12-31 | $1,627,968 | 73,200 | Shares | Sole | 2021-02-05 | |
| No filing history on record for this holder in this stock. | ||||||